FDA
approval
· 2026-03-30
FDA Approved: GLIPIZIDE — Supplemental Application (Actavis Pharma, Inc.)
Summary
FDA approved a supplemental application for glipizide by Actavis Pharma, Inc. under the ANDA pathway, enabling an additional or updated approval for the generic…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for GLIPIZIDE (GLIPIZIDE)